NEU neuren pharmaceuticals limited

Ann: 2023 Results webinar, page-9

  1. 2,516 Posts.
    lightbulb Created with Sketch. 686
    Yep, the bit that caught my attention when asked about acquisitions and partnerships "we're aware of our continuous disclosure obligations".

    For other questions (like relating to Autism) he was quite clear on saying that wasn't being planned. To me this sounds like there are discussions occurring, they simply haven't reached a point where a formal offer has been tabled where the market would have to be informed. Jon (in my opinion) has consistently done the right thing by investors so when it comes to further partnership agreements and potential acquisitions he will maximise shareholder value.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.85
Change
-0.110(0.85%)
Mkt cap ! $1.598B
Open High Low Value Volume
$12.82 $13.05 $12.53 $6.559M 511.8K

Buyers (Bids)

No. Vol. Price($)
1 1657 $12.83
 

Sellers (Offers)

Price($) Vol. No.
$12.85 6303 1
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.